Statistics for A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors
Total visits
views | |
---|---|
A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors | 0 |
Total visits per month
views | |
---|---|
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
java.util.UUID:9daa55e9-6d83-4e85-b4f7-1260100acc1c | 13 |
Fountzilas2021Phase-AAM.pdf | 8 |
java.util.UUID:5f834c96-70d7-439c-a2fc-b2e41077f86c | 6 |
java.util.UUID:7a0d83d2-adce-48af-8e03-35a99b07dbca | 1 |